View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Sponsored by Nuvisan Pharma Service

Nuvisan Pharma Services

Free White Paper

Nuvisan Pharma Services

By Nuvisan Pharma Service

Nuvisan Pharma Services

By Nuvisan Pharma Service
Enter your details to receive the free paper:

In order to keep up with the latest developments in the field of cGMP regulated biopharmaceutical analytics, NUVISAN has added several Mass Spectrometry (MS) techniques to its repertoire.

We will be the first CRO in Europe to provide the coupled method of CESI-MS (Capillary Electrophoresis+ Electrospray Ionization + Mass Spectrometry), which will enable us to identify and analyse proteins in a way that all existing approaches could not provide for biopharmaceuticals.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena